Accueil • Veille Scientifique • Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal ?-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial
JAMA • 2020.02.11
Tong S.Y.C., Lye D.C., Yahav D., Sud A., Robinson J.O., Nelson J., Archuleta S., Roberts M.A., Cass A., Paterson D.L., Foo H., Paul M., Guy S.D:, Tramontana A.R., Walls G.B., McBride S., Bak S., Ghosh N., Rogers B.A., Ralph A.P., Davies J., Ferguson P.E., Dotel r., McKew G.L., Gray T.L., Holmes N.E., Smith S., Warner M.S., Kalimuddin S., Young B.E., Runnegar N., Andresen D.N., Anagnostou N.A., Johnson S.A., Chatfield M.D., Cheng A.C., Fowler V.G. Jr, Howden B.P., Meagher N., Price D.J., van Hal S.J., O'Sullivan M.V.N., Davis J.S., Australasian Society for Infectious Diseases Clinical Research Network
- Clinical trial
- International
- Bacteremia, beta-lactams, Cefazolin, Clinical trial, Cloxacillin, Daptomycin, Floxacillin, MRSA, Vancomycin